Aerovate Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy AVTE

*Your capital is at risk

$2.68

+0 (+0%)

At Close: Jul 25, 2025

Currently predicting for Fri, 5 Jun 2026

AVTE Prediction Chart

AVTE Predictions History

Latest community submissions for AVTE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
tabithawasserman.299615 Amateur	Mar 9, 2022	$13.15 -96.98%	$12.50	X	94.80%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AVTE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AEROVATE THERAPEUTICS, INC.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by